This is especially true when the National Institute on Aging and Alzheimer's Association (NIA-AA) proposed the Aβ/tau/neurodegeneration (AT(N)) classification system to update the diagnostic criteria for AD recommended in 2011(Jack et al., 2018). The gene discussed is MAPT; the disease is Alzheimer disease.